- 专利标题： HEPATITIS B CORE PROTEIN MODULATORS
-
申请号： EP16847295.9申请日： 2016-09-15
-
公开(公告)号： EP3349580A1公开(公告)日： 2018-07-25
- 发明人: TURNER, William , ARNOLD, Lee, Daniel , MAAG, Hans , LI, Leping , BURES, Mark , HAYDAR, Simon , FRANCIS, Samson
- 申请人： Assembly Biosciences, Inc. , Indiana University Research and Technology Corporation
- 申请人地址： 11711 North Meridian Street Suite 310 Carmel, Indiana 46032 US
- 专利权人： Assembly Biosciences, Inc.,Indiana University Research and Technology Corporation
- 当前专利权人： Assembly Biosciences, Inc.,Indiana University Research and Technology Corporation
- 当前专利权人地址： 11711 North Meridian Street Suite 310 Carmel, Indiana 46032 US
- 代理机构： Harris, Jennifer Lucy
- 优先权： US201562218815P 20150915
- 国际公布： WO2017048950 20170323
- 主分类号： A01N57/00
- IPC分类号： A01N57/00
摘要：
The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.
公开/授权文献
- EP3349580B1 HEPATITIS B CORE PROTEIN MODULATORS 公开/授权日：2020-08-19
信息查询
